Stockscreener 앱 받기
2.29
0.44%
0.01
시간 외 거래:
2.30
0.010
+0.44%
전일 마감가:
$2.28
열려 있는:
$2.32
하루 거래량:
169.29K
Relative Volume:
0.46
시가총액:
$44.62M
수익:
-
순이익/손실:
$-30.26M
주가수익비율:
-1.1225
EPS:
-2.04
순현금흐름:
$-24.69M
1주 성능:
-0.87%
1개월 성능:
-15.81%
6개월 성능:
+35.50%
1년 성능:
-70.87%
1일 변동 폭
$2.22
$2.3448
1주일 범위
$2.21
$2.3792
52주 변동 폭
$1.11
$10.54
Annovis Bio Inc Stock (ANVS) Company Profile
명칭
Annovis Bio Inc
전화
484-875-3192
주소
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
ANVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.29 | 44.43M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-10 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2024-10-25 | 업그레이드 | Maxim Group | Hold → Buy |
| 2023-12-29 | 개시 | Canaccord Genuity | Buy |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
Annovis Bio Inc 주식(ANVS)의 최신 뉴스
How to forecast Annovis Bio Inc. trends using time seriesQuarterly Trade Summary & Daily Volume Surge Trade Alerts - Newser
Is Annovis Bio Inc. impacted by rising ratesTrade Analysis Report & Weekly Watchlist of Top Performers - خودرو بانک
Annovis Bio Inc. recovery potential after sell offPortfolio Performance Report & Long-Term Capital Growth Strategies - Newser
Risk adjusted return profile for Annovis Bio Inc. analyzedJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
Will Annovis Bio Inc. bounce back from current supportTrade Volume Summary & Free Fast Entry Momentum Trade Alerts - Newser
Forecasting Annovis Bio Inc. price range with options dataJuly 2025 Retail & Growth Focused Stock Reports - Newser
Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio - MSN
Analyzing drawdowns of Annovis Bio Inc. with statistical tools2025 Year in Review & Expert-Curated Trade Recommendations - Newser
How to escape a deep drawdown in Annovis Bio Inc.2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
What makes Annovis Bio Inc. stock attractive todayMarket Movement Recap & AI Optimized Trade Strategies - 강소기업뉴스
Technical analysis overview for Annovis Bio Inc. stockIndex Update & Fast Entry High Yield Stock Tips - Newser
What MACD and RSI say about Annovis Bio Inc.2025 Major Catalysts & Verified High Yield Trade Plans - Newser
Has Annovis Bio Inc. formed a bullish divergenceWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
Regression analysis insights on Annovis Bio Inc. performanceJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Annovis Bio Inc. stock outlook for YEAR2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
How sensitive is Annovis Bio Inc. to inflation2025 Stock Rankings & Verified Momentum Stock Ideas - خودرو بانک
Market Outlook: Does Annovis Bio Inc. stock have upside surprise potential2025 Geopolitical Influence & Advanced Technical Signal Analysis - خودرو بانک
Can Annovis Bio Inc. disrupt its industryJuly 2025 Pullbacks & Smart Allocation Stock Reports - خودرو بانک
Real time breakdown of Annovis Bio Inc. stock performanceJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - Newser
Price action breakdown for Annovis Bio Inc.Earnings Trend Report & Weekly Return Optimization Alerts - Newser
Best data tools to analyze Annovis Bio Inc. stock2025 Key Highlights & Smart Swing Trading Alerts - Newser
H.C. Wainwright lowers Annovis Bio stock price target to $10 on extended approval timeline By Investing.com - Investing.com Australia
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
H.C. Wainwright lowers Annovis Bio stock price target to $10 on extended approval timeline - Investing.com
Annovis Bio: HC Wainwright Maintains Buy, PT Down to $10 from $12 - AInvest
Annovis Bio price target lowered to $10 from $12 at H.C. Wainwright - TipRanks
Strategies to average down on Annovis Bio Inc.July 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
What candlestick patterns are forming on Annovis Bio Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - Newser
What is the dividend yield of Annovis Bio Inc.2025 Support & Resistance & Entry Point Strategy Guides - خودرو بانک
What’s the profit margin of Annovis Bio Inc.July 2025 Technicals & Real-Time Buy Zone Alerts - خودرو بانک
Annovis Bio CEO to Present at H.C. Wainwright Global Investment Conference - citybuzz -
Risk vs reward if holding onto Annovis Bio Inc.July 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Neurodegenerative Disease Pioneer Annovis Bio to Showcase Progress at Major Investment Conference - Stock Titan
Gainers Report: What makes Annovis Bio Inc. stock attractive today2025 EndofYear Setup & Fast Gain Stock Trading Tips - خودرو بانک
Aug Setups: What is Annovis Bio Inc. s P E ratio telling usBull Run & Expert Approved Momentum Trade Ideas - خودرو بانک
Annovis Bio Inc. Hits Oversold Level on RSI Indicator getLinesFromResByArray error: size == 0 - 강소기업뉴스
Annovis Bio Inc (ANVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):